Several recent studies have also confirmed the high expression levels of POLD2 in the pathogenesis of various malignancies, including breast cancer,19 glioblastoma,20 multiple myeloma,21 and bladder urothelial carcinoma.22 This evidence concerns the gene POLD2 and glioblastoma.